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AIMS AND OBJECTIVES 
1. To assess preoperative Eustachian Tube (ET) function using the inflation deflation 
technique and Valsalva maneuver in patients with mucosal chronic suppurative otitis 
media undergoing surgery for perforation closure. 
2. To investigate if there is any change in ET function following tympanoplasty in these 
patients. The null hypothesis is that there is no change in ET function following 
tympanoplasty 
3. To discover whether a patent ET is predictive of postoperative closure of perforation   
 
 
 
 
 
 
ABSTRACT 
Eustachian tube function before and after surgery in patients with mucosal 
chronic suppurative otitis media 
Introduction 
 The Eustachian tube (ET), also called the pharyngotympanic tube, is a narrow passage 
made of bony and cartilaginous parts connecting the middle ear cleft to the nasopharynx.  
Normal ET function is necessary for ventilation of the middle ear (ME), maintaining the ME 
space and drainage of ME secretions.  Any structural or functional abnormalities of ET can 
affect these functions and lead to negative ME pressure, fluid accumulation and, eventually, a 
perforation of the tympanic membrane.  The pathogenesis of mucosal chronic suppurative 
otitis media (CSOM) is thus believed to be linked to abnormal ET function. 
Materials and methods 
This study was performed in the ENT outpatient department at Christian Medical College 
Vellore, between May 2010 and July 2011. All patients aged 16 years and above with 
mucosal chronic suppurative otitis media (CSOM), who were scheduled to undergo surgery, 
were included in the study. A brief history of their problems and clinical findings, were 
entered into the proforma .Preoperatively otomicroscopic examination, pure tone audiogram, 
Valsalva maneuver and inflation-deflation test were done. Post operatively after 3 months, 
otomicroscopic examination, pure tone audiogram, Valsalva maneuver and tympanometry 
were done.  Of a calculated sample size of 104 (180 patients with 40% loss to follow up), 106 
patients were followed up. 
Results  
Preoperative Valsalva showed that the ET was patent in (54.9%). (62.6%)have 
blocked ET by the preoperative inflation-deflation test. 72.1% of the patients with a patent 
ET on Valsalva maneuver showed patent ET on the inflation deflation test also. The 
association between the 2 tests of ET function preoperatively was high and this was found to 
be statistically significant (p<0.01). When assessed by Valsalva maneuver and inflation-
deflation test preoperatively and tympanometry postoperatively, if a patient had a blocked ET 
preoperatively there was a higher chance of it changing than if a patient had a patent tube 
(p<0.001). The success rate of tympanic membrane closure was 78.4%.  Although the 
patients with non-patent ET had a higher rate of residual perforation, when assessed with 
Valsalva maneuver and inflation deflation test, there was no statistical correlation between 
preoperative eustachian tube status and postoperative graft status. 
Conclusion 
We arrived at 3 important conclusions in this study. Firstly, the ET appeared to be 
blocked in most patients with mucosal CSOM when assessed preoperatively with the 
inflation deflation test, whereas most appeared tube patent with the Valsalva maneuver. 
Secondly, there was a change in the ET function after surgery which was significant 
(p<0.001) when assessed with both Valsalva and inflation deflation preoperatively and 
tympanometry post operatively. The function of the ET tends to change from blocked 
towards patency, possibly due to the removal of the disease and return of normal 
physiological state after surgery.  
Finally, there was an increased tendency of a patient with blocked ET to develop a 
residual perforation, although this did not reach statistical significance.  
    
KEY WORDS 
Eustacchian tube , Valsalva maneuver, Inflation-deflation test.  
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PRESENT KNOWLEDGE AND REVIEW OF LITERATURE 
Introduction 
 The Eustachian tube (ET), also called the pharyngotympanic tube, is a narrow 
passage made of bony and cartilaginous parts connecting the middle ear cleft to the 
nasopharynx.  Normal ET function is necessary for ventilation of the middle ear (ME), 
maintaining the ME space and drainage of ME secretions.  Any structural or functional 
abnormalities of ET can affect these functions and lead to negative ME pressure, fluid 
accumulation and, eventually, a perforation of the tympanic membrane.   
 The pathogenesis of mucosal chronic suppurative otitis media (CSOM) is believed 
to be linked to abnormal ET function.
1
 Good preoperative ET function has been 
associated with high rates of success with regard to tympanic membrane closure.
2
 Higher 
failure rates are seen in patients with poor ET function.
3
 Closure of the tympanic 
membrane perforation may reduce chronic irritation of ME and thus encourage return of 
normal ET function .
4
 
Historical aspects of Eustachian tube anatomy and function 
 Alcmaeon of Sparta was the first to introduce the term Eustachian tube (ET) in 
400 BC.
5
 It was Eustachius Bartholomeus (1510 – 1574), who described the ET in his 
thesis Epistola de auditus organis.
6
 Antonio Maria Valsalva(1666 – 1723) described the 
osseous and cartilaginous part of the ET and identified the „dilator tubae‟ part of the 
tensor  veli palati muscle. The Valsalva maneuver which is used to assess the patency of 
the ET is named after him .
5
 Joseph Toynbee (1819 – 1856), a pioneer in aural pathology, 
described the muscles that open the ET.
7
Adam Politzer,‟ Father of modern Otology‟ 
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introduced the method of Politzerisation, by which air is inflated into the middle ear 
through the ET which decreases the tension in the middle ear and partly or completely 
remove secretions thus improving the conductive hearing apparatus.
8
 
Embryology 
The ET develops from the lateral extension of the endoderm of the first 
pharyngeal pouch (Figure 1). By the 10
th
 week of intrauterine life the epithelium 
differentiates, by 12 to 14 weeks the levator veli palati and tensor veli palate develop and 
the cartilage starts differentiating and epithelial rugae and glandular tissue develops.
9 
The 
length increases from 1mm at 10 weeks to 13mm at birth.  The lumen height increases 
and also the angle between the tensor veli palati and the cartilaginous ET become more 
acute.
10 
As the skull base grows and increases in size, the distance between it and the 
cartilaginous ET increases. The ET reaches adult size by 7 years of age.
11 
The angle 
between the ET and the Frankfurt horizontal plane changes from 10 degree in infants to 
45 degree in adults.
12
 
Figure 1: Development of ET and middle ear cleft 
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Adult Eustachian tube 
 The ET has an osseous and a cartilaginous part.  The length ranges from 31 to 38 
mm.
13
 The posterior one third (11 to 14 mm) of the adult ET is osseous and the anterior 
two third (20 to 25 mm) is cartilaginous. The osseous part starts from the middle ear 
(ME) and travels anteriorly and medially through the petrous temporal bone.  The medial 
wall of this part of ET lies close to the carotid canal and the labyrinth.
14
 The osseous ET 
is lined with epithelium similar to that of the ME and the cartilaginous part with mucosa 
similar to that of nasopharynx, consisting of ciliated cells and mucous glands.
15
 The ET 
takes a slowly curving inverted „S‟ curve from the ME to the nasopharynx.9 The 
nasopharyngeal end has an elevation called the torus. 
 The cartilaginous part has two arms, a short lateral lamina and a longer medial 
lamina.  The lateral arm has a constant height.  The medial arm is initially short, and 
increases to a height of 13mm just behind the attachment of the cartilage to the medial 
pterygoid plate.  Posteriorly the height decreases to 9mm and enters the petrous temporal 
bone.  Thus the dome shaped cartilage continues into the bone between the lumen and the 
tensor tympani muscle superiorly.
10, 16 
The nasal orifice is 8.5mm in height and it 
gradually decreases posteriorly to 3.5mm.  The nasopharyngeal end of the ET is attached 
to the medial pterygoid and the posterior part to the skull base.  The narrowest part of the 
ET is called the isthmus and it lies in the cartilaginous part.  It is around 20mm from the 
pharyngeal orifice and 0.65mm
2
 in cross section.  The tensor veli palate tendon is 
attached to this part in the lateral lamina suggesting that its contraction opens the isthmus 
to ventilate the ME and also protects the ME.
17
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 The ET is lined with pseudo stratified ciliated columnar epithelium which is 
continuous with that of the ME posteriorly and that of the nasopharynx anteriorly.  It also 
contains goblet cells rich in secretory granules, lysozymes and immunoglobulins, A, G, E, 
and M which contributes to the local immunodefence of the ET.
18 
The submucosa 
contains mucoserous glands which decreases in density with increasing age.
19
 
 The lateral membranous portion of the ET is defined in the middle portion of the 
cartilaginous ET.  Its medial boundary is submucosa of the lumen.  It is anchored 
superiorly to the inferior curvature of the lateral lamina.
10 
The tensor veli palate (TVP) 
takes its origin from the lateral lamina and the lateral membranous wall.
20
 
 The muscles associated with ET are: Tensor veli palati, Levator veli palati, 
salpingopharyngeus, and tensor tympani (Figure-2).  The bony part remains open and the 
cartilaginous ET is closed at rest.  It opens during swallowing, sneezing and yawning thus 
equalising the middle ear pressure to that of the atmospheric pressure.  Closure of the tube 
is achieved by the extrinsic forces of the surrounding deformed tissues and /or by the 
recoil of the elastic fibres or the tubal wall and cartilage.
10
 The TVP consists of two 
muscle bundles.  The more lateral bundle originates from the scaphoid fossa and the 
greater wing of sphenoid bone superior to the ET cartilage.  The muscle descends 
anteriorly, laterally and inferiorly to converge into a tendon that winds around the 
hammular process of the medial pterygoid and inserts into the posterior border of 
horizontal process of the palatine bone and palatine aponeurosis.  The more postero- 
superior muscle fibres extend into the semi canal of tensor tympani muscle and receive a 
second muscle slip from the tubal cartilage and the sphenoid bone.  The fibres converge 
to a tendon and winds around the processes cochleariformis and inserts into the neck of 
the malleus. This forms the tensor tympani muscle.
21, 22 
The medial bundle originates 
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from the posterior half of lateral membranous wall of ET.  The fibres descend and blend 
with the lateral bundle.  This also called the dilator tubae is the primary dilator of the 
ET.
21 
LVP arises from the inferior aspect of the petrous temporal bone.  It lies 
inferolateral to the inferior margin of the medial lamina of the anterior ET and inferior to 
the medial lamina of the posterior ET suggesting that the LVP opens the anterior 
cartilaginous portion of the ET by rotating the medial lamina with increased dimension of 
the muscle body when it contracts.
23
 The Salpingopharyngeus muscle arises from the 
medial and inferior border of tubal cartilage and passes inferoposteriorly to blend with the 
Palatopharyngeal muscle.  The fibres are very thin and lack ability for any physiological 
function.
10
 
Figure-2: Muscles attached to Eustachian tube. 
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 The middle ear together with the ET, aditus, antrum, and the mastoid air cells is 
called the middle ear cleft.  The ME has a roof, a floor, medial, lateral, anterior and 
posterior walls.  The anterior wall is narrow as the medial and lateral walls converge.  The 
lower portion of the anterior wall consists of a thin plate of bone covering the carotid 
artery.  The smaller upper part has two parallel tunnels placed one above the other.  The 
lower one leads to the bony ET while the upper, separated from the bony ET contains the 
tensor tympani muscle. 
Function of ET 
 Three physiological functions have been described for the ET.
24 
(Figure.3).  
1) Ventilation of the middle ear to equilibrate the middle ear pressure with that of the 
atmosphere.  2) To transport the middle ear secretions to the nasopharyx by mucociliary 
clearance.  3) To protect the middle ear from nasopharyngeal sound pressure and 
secretions.  
Ventilatory function:   
 The transducer function (necessary for the normal hearing mechanism) of middle 
ear is optimal when the ambient and middle ear pressures are equal.  This is facilitated by 
the opening of the ET.  The ME is considered as a rigid non-collapsible gas pocket 
surrounded by vascular mucosa.  Gases are exchanged between the middle ear spaces and 
the mucosa.  Partial pressure of gases in the mucosa approximates that of microcirculation 
of middle ear mucosa.  Middle ear O2 is slightly higher than in microcirculation, whereas 
CO2 is in equilibrium.
25 
The diffusion gradient is created by N2 partial pressures and 
relatively inert gases.  When the ET is opened by the paratubal musculature during 
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deglutition and other maneuvers, the pressure difference between the environment and the 
ME are equalised by the inflow and outflow of gases.  The ventilator function maintains 
near equilibrium between internal and external pressures, thus maintaining the near 
optimal transducer function of the ME and preventing pathological consequences that 
result from unabated ME to mucosa gas exchange.  In an attempt to describe normal ET 
function using micro flow technique in a pressure chamber, Elner et al
26 
studied 102 
adults with intact tympanic membrane and no ear disease.  The patients were divided into 
four groups according to their ability to equilibrate static relative positive and negative 
pressures of 100mm of water in the ME.  Group 1 equilibrated the pressure completely; 
group 2 equilibrated positive pressure, but had a small residual negative pressure in the 
ME.  Group 3 were capable of equilibrating only relative positive pressure with a small 
residual remaining, but not negative pressure; those in group 4 were unable to equilibrate 
any pressures. This indicated decreased stiffness of ET in group 2 to 4 when compared to 
group 1.  This study also showed that 95% of normal adults could equilibrate an applied 
positive pressure and 93% could equilibrate applied negative pressures to some extent by 
active swallowing.  However 28% of the subjects could not completely equilibrate either 
applied positive or negative pressure or both. 
Protection, drainage and clearance 
The ET, ME and mastoid air cells can be considered as a flask with a long narrow 
neck.
27 
The nasopharyngeal end can be considered as the mouth of the flask, the narrow 
neck, the isthmus of the ET and the bulbous portion the ME and the mastoid air cells.  
Fluid flow through the neck will depend upon the pressures at both ends, the radius and 
length of the neck and the viscosity of the fluid. When a small amount of fluid is instilled 
into the mouth of the flask, fluid stops somewhere at the narrow neck as a result of 
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capillarity at the neck and positive pressure that develops in the chamber of the flask.  If 
there is a perforation of the tympanic membrane, secretions can move from the 
nasopharynx to the ME as there is no positive pressure from the mastoid to prevent the 
reflux.  If a high negative pressure develops in the ME and the mastoid, fluid gets 
aspirated into the ME and mastoid from the nasopharynx. Similarly if a high positive 
pressure is applied at the nasopharynx, fluid insufflates into the ME.  The other factors 
which affect the flow of gas and fluid through the ET are 1) mucociliary clearance.
28, 29
, 
2) active tubal opening and closure, 3) Surface tension characteristics.
30
 
Figure.3 Functions of ET (ventilation, protection and clearance) 
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Pathophysiology of middle ear disease 
 There are various factors associated with the etiology and pathogenesis of ME 
disease.  These include ET dysfunction, other host related factors like genetic 
predisposition, age, prematurity, allery, immunodeficiency, craniofacial abnormalities, 
environmental factors like upper respiratory tract infections, attendance to day care, 
number of siblings, absence of breast feeding, and socioeconomic factors. ET dysfunction 
is one of the most common causes of ME diseases.  There are many studies which show 
sufficient evidence to support the „hydrops ex vacuo‟ theory of Adam Politzer, which 
says that when the ET is blocked and there is edema of the ME mucosa, ME under 
pressure develops and there is transudation of serous fluid into the ME.
31
Anatomic or 
functional obstruction of the ET is the primary cause of ME negative pressure.  Anatomic 
obstruction is frequently due to inflammation mostly due to viral infection.  Others are 
inflammation due to allergy or obstruction at the nasopharyngeal end due to adenoids or 
tumour and the middle ear due to granulations. Functional causes are floppy cartilage, 
dysfunction of the TVP muscle, constriction of the ET while swallowing and otic 
barotrauma.  Secondary cause of ME negative pressure is inflammation in the ME. This 
can lead to obstruction of the bony ET with secretions, thus impairing the pressure 
regulatory and clearance functions of the ET. ME under pressure leads to acute otitis 
media (Figure.4) and otitis media with effusion (Figure.5).  Acute otitis media with 
otorrhea occurs when there is rupture of tympanic membrane.  If acute otitis media with 
tympanic membrane rupture does not heal spontaneously or following treatment it can 
lead to chronic otitis media (Figure.6).  Negative ME pressure also enhances reflux and 
insufflations of secretions from nasopharynx to ME. Otitis media can also occur in 
11 
 
dysfunction of the ET due to reflux or insufflation of nasopharyngeal secretions into ME, 
which can occur in condition like patulous ET or cleft palate.  In chronic suppurative 
otitis media the ME and mastoid get infected from the nasopharyngeal secretions and the 
contaminants from the external auditory canal (Figure.7).  One of the most important 
factors associated with otitis media in infants and young children is immaturity of the 
structure and function of the ET and immaturity of the immune system.
32
 
 The antecedent event in an acute otitis media is a viral upper respiratory tract 
infection.  This leads to congestion and inflammation of the mucosa of the nasopharynx 
and ET and thus obstruction of the ET.  Further development of ME under pressure 
occurs especially in mastoids, where the mastoid air cell system (MACS) volume is less.  
Larger MACS will partially protect the ME from development of a pathological under 
pressures by allowing for a decreased frequency of ET openings and/or less efficient ET 
openings when compared to a smaller MACS volume.
33
  Negative ME pressure is 
followed by aspiration of pathogens (viral and bacterial) into the ME from the 
nasopharynx.   This along with the secretions from the middle ear mucosa gets collected, 
allowing the pathogens to proliferate that eventually leads to suppuration.  In a study by 
Buchman
34
 and colleagues where 32 healthy adults were subjected to a nasal inoculation 
of respiratory syncytial virus, 18 (56%) of them were infected with the virus and by the 
6
th
 day only 46% of the infected subject had a normal ME pressure (> 100mmof H2O), 
showing the relationship between viral upper respiratory tract infection and otitis media.
 Otitis media with effusion has a similar sequence of events as that of acute otitis 
media.  Swarts
35
 and associates were also able to produce ME effusion in the monkey 
shortly after inducing negative middle-ear pressure by flushing the middle ear with CO2. 
This study confirm the „hydrops ex vacuo‟ theory of the pathogenesis of ME effusion, 
which postulates that in the absence of ET opening, the gas exchange from the middle ear 
12 
 
into the microcirculation of the mucous membrane causes a middle-ear under pressure, 
followed by transudation of effusion. 
 Tympanic membrane perforations that are acute are usually secondary to AOM 
which may also occur during the course of chronic otitis media with effusion .
36 
Chronic 
perforation of the tympanic membrane usually occurs when an acute perforation fails to 
heal. When there is acute drainage through perforated tympanic membrane that persists 
for 2 weeks to 3 months or longer the infection is chronic suppurative otitis media. There 
is no consensus on the duration of otorrhea to be termed chronic; however, as per the 
WHO definition.
37
,  otorrhoea persisting through a perforated tympanic membrane for > 2 
weeks is believed to be due to CSOM. It has been shown that in patients with chronic 
otitis media with effusion there is degeneration of lamina propria of the tympanic 
membrane with decrease in thickness of fibrous layers.
38
 This weakness of tympanic 
membrane predispose to perforation with less chance of spontaneous healing. Thus the 
pathogenesis of CSOM is linked to abnormal ET function.
32 
In inactive mucosal CSOM, 
the structure and often the hearing is impaired by the presence of a permanent tympanic 
membrane defect but there is no active infection or mucus discharge.  Such an ear may 
remain inactive, become active or may even occasionally heal.  Active mucosal CSOM is 
associated with resorption of parts or all of the ossicular chain (resoptive osteitis).
39
 
(Figure.8). 
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Figure.4: Acute suppurative otitis media 
 
 
Figure.5: Otitis media with effusion 
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Figure.6: Chronic suppurative otitis media - tubotympanic disease 
 
 
Figure.7 Infected fluid in the middle ear 
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Figure.8:Resorptive osteitis 
 
Surgical treatment of CSOM tubotympanic disease 
The main objectives of surgery in patients with CSOM tubotympanic disease 
(TTD) are  
1) To remove the active disease and promote healing 
2) To restore an air filled ME cavity and prevent recurrence.  
3) To prevent complications 
4) To restore hearing function 
The surgical procedures often done are myringoplasty, tympanoplasty and cortical 
mastoidectomy with tympanoplasty.  Myringoplasty (Figure.9) involves excision of the 
16 
 
edges of the perforation and placement of a graft of temporalis fascia or perichondrium by 
an underlay or overlay technique to close the perforation.  Tympanoplasty involves 
reconstruction of tympanic membrane and/or the ossicular chain.  Studies on outcomes in 
terms of tympanic membrane uptake in these surgeries have been reported to be 78% and 
95% in the hands of trainees and senior staff respectively.
40 
Many authors suggest that a 
cortical mastoidectomy (Figure.10) should be carried out at the same time as 
myringoplasty in active ears and inactive ears.
41 
In a study by Mishiro et al
42
 in patients 
with mucosal CSOM, 251 ears were operated and followed up for one year. It was 
divided into two groups; group A with 147 patients underwent tympanoplasty with 
mastoidectomy and group B with 104 tympanoplasty without mastoidectomy. Graft 
success rates were 90.5% in group A and 93.3% in group B. There was no statistically 
significant difference in graft success rate. Graft success rates of discharging ears were 
90.0% in group A and 85.7% in group B. Graft success rates of dry ears were 90.7% in 
group A and 94.4% in group B. There was no statistically significant difference between 
discharging ears and dry ears. The rates of the postoperative air-bone gap within 20dB 
were 81.6% in group A and 90.4% in group B, without a statistically significant 
difference. This study shows that mastotoidectomy need not be combined with 
tympanoplasty for non cholesteatomatous CSOM, even if the ear is discharging. 
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Figure.9: Myringoplasty 
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Figure.10: Cortical mastoidectomy 
 
 
Eustachian tube function tests 
 There are various tests to assess the function of the ET. These include pneumatic 
otoscopy.
43
, nasopharyngoscopy and ET endoscopy
44 
and tympanometry. The latter is an 
objective way of determining ME pressure and thus the function. It is used to test the 
condition of the middle ear and mobility of the tympanic membrane by creating variations 
of air pressure in the ear canal. A compliance peak on a tympanogram indicates that the 
ear canal and middle ear pressures are equal, and that acoustic transmission through the 
middle ear is maximal. Tympanograms (Figure.11) are classified with respect to this 
peak.
45 
Some of the classical tests of tubal patency include Valsalva maneuver, Toynbee 
test, ET catheterization and Politzerisation.  When the tympanic membrane is intact and 
19 
 
the ME inflates following Valsalva or Politserisation, then the tube is not totally 
obstructed.  Similarly if the tympanic membrane is not intact, the passage of air into the 
ME indicates ET patency.  Elner et al
26
 reported that 86% of otologically normal adults 
could perform Valsalva.  The other tests include dye studies with fluroscien.
46
, 
saccharine.
47
 and sonotubometry.
48
 
Figure.11: Tympanogram 
 
Drawbacks of the ET function tests: 
Otoscopy cannot differentiate between a functional impairment and mechanical 
obstruction of the ET.  Valsalva maneuver is an objective method of assessment of ET 
function and is difficult to perform in the paediatric age group. Catheterization can 
traumatise the ET while inserting the catheter.  Tympanometry which is done in an intact 
tympanic membrane gives us only relative qualitative information of the tubal function. 
  
20 
 
 
Figure 12: Tympanometer – used for measuring inflation-deflation test. 
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Inflation-deflation test was first reported by Flisberg et al.
49 
It can be done in ears with 
chronic suppurative otitis media with a perforated drum, in patients who have undergone 
myringotomy and grommet insertion for otitis media with effusion and also in an intact 
tympanic membrane. The test is easy to perform, non-invasive and reproducible. It is 
possible by this method to determine at which level of negative or positive pressure 
applied within the ear space air passes through the tube during swallowing. (Figure.13, 
14) 
Figure.13: Inflation test of Eustachian tube function 
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Figure.14: Deflation test of Eustachian tube function 
 
 Takahashi et al
50
 reviewed 78 patients with non cholesteatomatous chronic otitis 
media, without ossicular damage. ET pressure-regulation functions were examined using 
an inflation-deflation test, and postoperative hearing levels were measured. Patients with 
poor pressure regulation showed a significantly higher incidence of poor outcomes, poor 
hearing recovery, spontaneous perforation of the tympanic membrane, or persistent wet 
condition.  Uzun
51
 reported 61 ears with pars tensa cholesteatoma who underwent 
tympanoplasty with cartilage palisades or fascia. The authors evaluated preoperative ET 
function using the Valsalva maneuver and found that late hearing results were better in 
patients with preoperative positive Valsalva maneuver than they were in those with 
negative maneuver. With respect to ears with poor tubal function, hearing results were 
23 
 
significantly better in those treated with cartilage palisade tympanoplasty than they were 
in those treated with fascia reconstruction. The authors suggested that cartilage palisade 
tympanoplasty might be a better reconstruction option for patients with poor ET function.  
Choi et al
52
 in their study of in their study of 137 patients with non cholesteatomatous 
ears found that a successful type 1 tympanoplasty and restoration of well aerated ME and 
good ET function permit better compliance of tympanic membrane and predictive of 
improved postoperative hearing.  According to a study done by Kurien et al
53
, the ET 
inflation deflation test is a sensitive test for predicting aditus patency in patients with dry 
ear and hence could be used to avoid unnecessary mastoid surgery 
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MATERIALS AND METHODS 
This study was performed in the ENT outpatient department at Christian Medical 
College Vellore, between May 2010 and July 2011. All patients aged 16 years and above 
with mucosal chronic suppurative otitis media (CSOM), who were scheduled to undergo 
surgery, were included in the study. A brief history of their problems and clinical 
findings, were entered into the proforma. Otomicroscopic examination was performed to 
assess the size and site of the tympanic membrane perforation. The presence of 
tympanosclerosis, granulations, discharge and exposure of round window or ossicles was 
noted. Details were entered into the proforma. 
Exclusion criteria: Presence of any of the following conditions: 
 Profusely discharging ear 
 Cholesteatoma 
 Immunosuppression 
 Poorly controlled diabetes mellitus 
Methods:   
a) Audiological assessment 
Hearing assessment was performed by pure tone audiometry to note the mean value of the 
air-bone gap at 500, 1000, 2000 and 3000 Hz. Hearing loss was quantified as per 
Goodman‟s scale as follows: 
25 
 
 
Mild    -     26-40 dB 
Moderate  -     41-55 dB 
Moderately severe  -     56-70 dB 
Severe   -     71-90 dB 
Profound  -       > 90 dB 
b) ET patency was assessed on the day prior to surgery by the following method: 
1. Valsalva maneuver  
 In this maneuver positive pressure is built in the nasopharynx by sealing it at the 
nasal and pharyngeal openings so that air enters the ET. This was done by asking the 
patient to pinch his nose and close his mouth and blow air into his ears. ET was deemed 
to be patent if the patient got a subjective sensation of opening of the ear or air passing 
through the ear. This test was done both pre and postoperatively.  
Inflation-deflation test  
The external auditory canal of the patient was fitted with a rubber ear tip of 
corresponding size so as to maintain an air tight seal. The otoadmittance probe was 
connected to a standard otoadmittance meter (GSI Ltd). The middle ear was then inflated 
with a constant flow of air until the ET is opened passively. This was marked by a sudden 
fall in pressure (opening pressure). This was the forced response test.  
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The middle ear pressure was then equilibrated by performing 5 consecutive 
swallows with an interval of ten seconds in between to prevent strain on the pharyngeal 
muscles (active tubal function). The residual pressure after 5 swallows if any was 
recorded. The deflation phase of the test was performed by giving a pressure of - 400 mm 
to the middle ear and asking the patient to swallow again. The pressure remaining in the 
middle ear after 5 consecutive swallows was recorded. The ET was considered to be 
patent if there was no or minimal residual pressure during both inflation and deflation. 
The results of the inflation deflation test were categorised based on whether the 
patients could equalise pressure or have a residual pressure of 100mmof H2O or less as 
being patent. Those patients who could not equalise pressures on swallowing either with 
positive or negative pressures to <100mm of H2O were deemed to have a non-patent or 
blocked ET. This group included patients in whom there was no change with either 
positive or negative pressure.
54  
The participants of the study underwent myringoplasty or 
tympanoplasty with cortical mastoidectomy on the following day. The tympanic 
membrane perforation was closed using a temporalis fascia graft. 
c) Postoperative assessment 
1. Otomicroscopy was performed to note the integrity of the tympanic membrane. 
The following specific features were observed with respect to the tympanic 
membrane: 
i. 1 – Normal 
ii. 2 – Perforation 
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iii. 3 – Retraction 
iv. 4 - Tympanosclerosis 
v. 5 – Granulation over graft 
 
2. Postoperative pure tone audiometry was performed at the same frequencies as 
preoperatively. 
3. Postoperative middle ear aeration was assessed in those patients with intact 
tympanic membranes using tympanometry. An automated otoadmittance meter 
was used to record a tympanogram. The results of tympanometry were expressed 
as follows: 
A-normal  
As-Reduced compliance at ambient pressure  
Ad-Increased compliance at ambient pressure 
B-flat or dome shaped  
C-Maximum compliance at pressures more than -100 mm H2O (Blocked 
ET tube) 
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Sample size calculation: 
Sample size for this study was calculated using the following formula 
2
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Where,  
n = sample size 
p1 = incidence of blocked ET postoperatively in patients with patent ET preoperatively 
p2 = incidence of blocked ET postoperatively in patients with blocked ET preoperatively 
P = (p1 +p2) / 2 
Q = 1 – P 
 Alfa = 5% 
 Beta = 80% 
This calculation was derived based on the study by Choi HS et al
52 
in which poor 
ET function was seen postoperatively in 40% of those patients with CSOM who had 
minimal or no residual pressure (good ET function) preoperatively and 67% of those who 
had moderate to large amounts of residual pressure ( poor ET function) preoperatively. 
Using these figures we estimated that in order to detect this difference at 5% level of 
significance, with a power of 80% the required sample size is 57 in each group. With a 
speculated loss to follow up of 40%, the number required in each group will be 90 
subjects (total of 180 subjects). 
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Statistical analysis 
Descriptive analysis was used for frequency calculation. This was used to analyse 
the preoperative and postoperative ET function. Pearson Chi-square test and Fisher‟s 
exact test was used for categorical data to check the association. The change in ET 
function and the association of the ET function with graft uptake were analysed using 
Pearson Chi-square test. 
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RESULTS AND ANALYSIS 
Of the 182 patients in our study who underwent surgical closure of tympanic 
membrane, 106 of them were reviewed postoperatively over a period of 3 to 15 months.  
Table 1: Distribution of age of study patients (n = 182) 
Age (yrs) Number (%) 
<40 133 (74.1) 
>40 49 (26.9) 
Total 182 
 
Figure 15: Age distribution of study patients 
133 (73%)
49 (27%)
< 40 years
> 40 years
 
The age range was 16-59 years with a mean age of 32.6 years. Most patients 
(74.1%) of them were below the age of 40 years or less. This was probably because it was 
patients in this age group who chiefly sought surgery for ear discharge and hearing loss. 
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Table 2: Distribution of sex (n = 182) 
Sex Number (%) 
Male 105 (57.6) 
Female 77 (42.3) 
Total 182 
 
Figure.16: Sex distribution of study patients 
 
There were more males than females. 
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Table 3: Laterality of disease in affected patients (n = 182) 
Side Number (%) 
Unilateral 102 (56) 
Bilateral 80 (44) 
Total 182 
 
Unilateral disease (56%) was slightly more common than bilateral disease (44%). 
 
Figure 17: Distribution of laterality of ear disease: 
102 (56%)
80 (44%)
0
20
40
60
80
100
120
Unilateral disease Bilateral disease
Series1
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Table 4: Distribution of duration of ear discharge (n=182) 
 
 
The duration of the ear discharge ranged from (0.08 yrs to 50 yrs).  While most 
patients had ear discharge for less than 10 years, a significant number (41.2%) had 
discharge of > 10 year‟s duration. Of these, only a small proportion had sought surgery. 
Figure 18: Distribution of duration of ear discharge 
 
107 (59%)
75 (41%)
< 10 years
> 10 years
 
Duration of ear discharge Number (%) 
< 10yrs 107 (58.8) 
>10yrs 75 (41.2) 
Total 182 
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Table 5: Distribution of revision surgery (n = 182) 
Previous surgery Number (%) 
Revision surgery 14 (7.6) 
First surgery 168 (92.3) 
Total 182 
Most of the ears (92.3%) were operated for the first time and only 7.6% had 
undergone revision surgery. 
Figure 19: Distribution of revision surgery 
14 
(8%)
168 (92%)
Revision surgery
First surgery
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Table 6: Distribution of co morbidities (n = 182) 
Comorbid conditions Number (%) 
Present 21 (11.5) 
Absent 161 (88.5) 
Total 182 
11.5% of the patients had comorbid conditions like diabetes mellitus, hypertension, 
hypothyroidism or bronchial asthma. 
Figure 20: Distribution of comorbid conditions 
21 (12%)
161 (88%)
Comorbid conditiond 
present 
Comorbid conditiond 
absent
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Table 7: Distribution of perforation size (n = 182) 
Size of perforation Number (%) 
Small / Moderate 36 (19.8) 
Large / Subtotal 146 (80.2) 
Total 182 
Most (79.6%) of the patients had a large or subtotal sized perforation.  
Table 8: Distribution of state of middle ear mucosa (n = 182) 
Middle ear mucosa Number (%) 
Dry 92 (50.5) 
Moist 90 (49.5) 
Total 182 
Dry and moist perforations were almost equally distributed.  
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Table 9: Distribution of preoperative Valsalva maneuver test results (n = 182) 
Preoperative Valsalva maneuver test results Number (%) 
Patent 100 (54.9) 
Not patent 82 (45) 
 
Figure.21: Distribution of preoperative Valsalva maneuver 
100 (55%)
82 (45%) Valsalva patent
Valsalva nonpatent 
 
Preoperative Valsalva showed that the ET was patent in a little over half of the 
patients. Thus, this test of ET function showed that ET dysfunction was not an important 
cause of the disease in this group of patients. 
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Table 10: Distribution of preoperative inflation and deflation test results (n = 182) 
Preoperative inflation & deflation test results Number (%) 
Patent 68 (37.4) 
Not patent 114 (62.6) 
Total 182 
Figure.22: Distribution of preoperative inflation deflation test 
68 (37%)
114 (63%)
Inflation deflation 
patent
Inflation deflation 
nonpatent 
 
The other test of ET functioned employed in this study was the inflation-deflation 
test. The test was done in patients with mucosal chronic suppurative otitis media 
preoperatively. Most patients appeared to have blocked ET by the preoperative inflation-
deflation test. The results of this test are quite different from that of the Valsalva test 
which showed that a little over half the patients had patent ET. 
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Table 11: Distribution of antral contents (n =114) 
Antral mucosa Number (%) 
Normal mucosa 57 (50) 
edematous mucosa 57 (50) 
Total 114 
Almost equal numbers of patients had either edematous or normal mucosa. 
 Table 12: Distribution of aditus status (n =114)  
Aditus status Number 
Patent 57(50) 
Blocked 57(50) 
Total 114 
Equal numbers of patients had blocked and patent aditus intra operatively. This is 
probably related to the status of the antral mucosa. Thus patients with edematous mucosa 
would probably have a blocked aditus. 
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Table 13: Association between preoperative Inflation deflation test result and 
preoperative Valsalva result  
 
Preoperative 
Valsalva test 
result 
I-D patent I-D not patent Test used for 
significance 
P value 
Patent 49 (72.1%) 51 (44.7%) Pearson Chi- 
square without 
Yates 
correction 
0.000* 
Not patent 19 27.9%) 63(55.3%) 
 
 
72.1% of the patients with a patent ET on Valsalva maneuver showed patent ET 
on the inflation deflation test also. The association between the 2 tests of ET function 
preoperatively was high and this was found to be statistically significant (p<0.01). 
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Postoperative follow up was obtained in 106 patients, all of whom underwent 
tympanometry and otoscopy.   
 
Table 14: Distribution of postoperative results (n = 106) 
Postoperative 
tympanic membrane  status 
Number (%) 
Intact tympanic membrane 83 (78.4) 
Residual perforation 23 (21.6) 
Total 106 
 
There were a total of 106 patients who came back for follow up. The success rate of 
tympanic membrane closure was 78.4%.  21.6% had a residual perforation.  
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Table 15: Distribution of postoperative tympanometry test results (n =83) 
 
 
 
Postoperative tympanometry was done to assess the middle ear status and the ET 
function in all those with intact tympanic membranes.  72.2% had a normal postoperative 
tympanometry and 27.7% had an abnormal tympanometry. The presence of B curves 
suggests either the presence of middle ear fluid or thickened tympanic membrane, those 
with C curves probably had ET block. 
Postoperative tympanometry test results Number (%) 
A, As, Ad 60 (72.2) 
C, Cs, B 23 (27.7) 
Total 83 
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Table 16: Distribution of postoperative Valsalva test results (n = 106) 
Postoperative Valsalva maneuver test results Number (%) 
Patent 61 (57.5) 
Not patent 45 (42.5) 
Total 106 
Figure 23: Distribution of postoperative Valsalva maneuver 
61 (58%)
45 (42%)
Valsalva patent
Valsalva nonpatent
 
There was an increase in the number of patients with postoperatively patent ET 
(57.5%) when performing the Valsalva maneuver.  
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Table 17: Comparing the change in ET function assessed by Valsalva maneuver 
preoperatively and Valsalva maneuver postoperatively 
 
Preoperative 
Valsalva 
maneuver test 
result 
Change present 
in ET function 
assessed by 
Valsalva 
maneuver (%) 
No change in 
ET function 
assessed by 
Valsalva 
maneuver 
(%) 
Test used for 
significance 
P value 
Patent 12(48) 48(59.2) 
Pearson Chi- 
square without 
Yates 
correction 
0.320 
Not patent 13(52) 33(40.7) 
 
Thus, several patients with preoperatively blocked ET on Valsalva maneuver had 
a change in ET function postoperatively. A greater number of patients with blocked ET 
showed change when assessment was done by Valsalva maneuver. However, the 
difference between the groups was not found to be statistically significant (p=0.32). 
When ET function was assessed by Valsalva maneuver preoperatively and by 
tympanometry postoperatively, the change in ET function was more apparent (Table 18), 
particularly for patients who had a blocked ET preoperatively. An „A‟ tympanogram was 
interpreted as an intact tympanic membrane with a patent ET. 
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Table 18: Comparing the change in ET function assessed by Valsalva maneuver 
preoperatively and tympanometry postoperatively 
Preoperative 
Valsalva 
maneuver test 
result 
Change present  in ET 
function assessed by 
tympanometry 
(%) 
No change in 
ET function 
assessed by 
tympanometry 
(%) 
Test used for 
significance 
P value 
Patent 9(30.0%) 39(73.5%) Pearson Chi- 
square 
without Yates 
correction 
< 0.001 
Not patent 21(70.0%) 14(26.4%) 
 
When assessed by Valsalva maneuver preoperatively and tympanometry 
postoperatively, if a patient had a blocked ET preoperatively there was a higher chance of 
it changing than if a patient had a patent tube (p<0.001). Conversely, if a patient had a 
patent ET preoperatively, there was not much change in the ET function postoperatively. 
The difference between the two groups those with patent and non-patent ET was 
statistically significant (p<0.001). 
The analysis was repeated using the inflation deflation test preoperatively and 
tympanometry postoperatively (Table 19). Here again, an A tympanogram with an intact 
tympanic membrane was indicative of a patent ET. 
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Table 19: Comparing the change in ET function assessed by inflation deflation test 
preoperatively and tympanometry in the postoperative period 
Preoperativ
e inflation 
deflation 
test result 
Change present in 
ET function assessed 
by 
tympanometry(%) 
No change in ET 
function assessed 
by tympanometry 
(%) 
Test used for 
significance 
P value 
Patent 10 (22.2) 25 (65.8) Pearson Chi- 
square without 
Yates 
correction 
< 0.001 
Not patent 35 (77.8) 13(34.2) 
 
Change in ET function following surgery was also assessed by the inflation 
deflation test. Here again, patients with preoperatively diagnosed ET block by the 
inflation deflation test were more likely to show a change in ET function than those with 
preoperatively patent ET. This difference between those with preoperatively patent and 
blocked ET was statistically significant (p< 0. 001). 
We then analysed the data to see if the preoperative ET function test result was 
predictive of closure of the perforation. The analysis was done first with the results of the 
inflation deflation test and then with the Valsalva maneuver results. 
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Table 20:  Association between preoperative inflation-deflation test result and 
successful closure of perforation 
 
 
Preoperative 
inflation deflation 
test result 
Intact tympanic 
membrane 
Residual 
perforation 
Test used 
for 
significance 
p-value 
Patent 35 (42.2%) 5 (21.7%) Pearson 
Chi- square 
without 
Yates 
correction 
0.074 
Not patent 48 (57.8%) 18 (78.3%) 
 
 
Although the patients with non-patent ET had a higher rate of residual perforation 
(78.3%), the difference between the two groups was not significant (p=0.07).  
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Table 21: Association between preoperative Valsalva test result and successful  
closure of perforation   
 
 
 
 
 
    
 
   The same association was looked at with preoperative Valsalva maneuver and a similar 
result was seen.  So the ET function does not impact on successful closure of perforation. 
This could be because a number of patients had a change in ET function following 
closure of the perforation. 
 
 
Pre OP Valsalva 
maneuver test 
result 
Intact tympanic 
membrane. 
Residual 
perforation 
Test used 
for 
significance 
p-value 
Patent 48 (57.8%) 12 (52.2%) Pearson 
Chi- square 
without 
Yates 
correction 
0.628 
Not patent 35 (42.2%) 11 (47.8%) 
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DISCUSSION 
The etiopathology of middle ear infection can be attributed to many causes of 
which ET dysfunction is considered to be a very important factor. Middle ear infection 
leads to further edema and obstruction of the ET.
5 
Whether ET dysfunction is a cause or a 
result of chronic otitis media has been a matter of much debate.  Several methods like 
Valsalva maneuver, Toynbee manoeuvre, ET catheterization, Politzerisation, fluroscein 
dye method, saccharine test sonotubometry, inflation deflation method, and 
tympanometry have been described for the assessment of the ET function and different 
results have been obtained. Among all these tests, the Valsalva test and the inflation 
deflation test have proved to be the most reliable and popular.
55‟56 
 ET block is usually transient in many patients with mucosal CSOM. In normals, 
too, there is diurnal variation in ET patency. Brattmo et al 
57
 study showed that middle ear 
pressure regulation is a dynamic process and that at various periods during the day and 
the night, the ET could be blocked or patent. He also found that there was a significant 
difference in the diurnal changes in the middle ear pressure in patients with central 
perforation compared to those with normal healthy ears. 
 The results of different tests of ET function often show disparate results. This is a 
big drawback when comparison of results of ET function using different techniques is 
performed. MacKinnon
58
 found that a number of patients who had good ET function on 
Valsalva maneuver had a poorly functioning ET on the aspiration deflation study. In the 
present study we found, however, that there was a good correlation between the results of 
the Valsalva test and inflation deflation test. Postoperatively, however, the results of 
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tympanometry and Valsalva test were quite disparate. One of the reasons for this could be 
that the manoeuvre was not performed properly. There could have been a number of 
patients who despite adequate training could not perform a proper Valsalva and were 
labelled as having blocked ET. Another reason could be that the ET function is variable 
and can give different results at different points of time. 
 The Valsalva maneuver is simple to perform and can be performed at the clinic or 
bedside and does not require much time to evaluate. Many authors have utilised this 
technique to evaluate ET function. It is an easily performed test not requiring any extra 
equipment and hence could be routinely performed for all patients undergoing middle ear 
surgery. Tos
55
 studied both squamous and mucosal chronic otitis media using the 
Valsalva maneuver and found that the poorest function was in those with squamous 
disease and active mucosal chronic otitis media. The dysfunction was least in those with 
inactive chronic mucosal otitis media. Andreasson and Harris
56 
in their study felt, 
however, that training is needed to perform a Valsalva maneuver. The Valsalva maneuver 
does not reflect on the normal physiological function of the ET. The present study is 
comparable with results of other studies. When Valsalva maneuver was used to assess the 
ET patency, many authors found that the ET was patent in the majority 
55, 56, 57, 58, 59
. The 
exact amount of pressure generated while doing Valsalva is not measured. The pressures 
generated are high and may possibly force open the ET. The major inference that we can 
make from a positive Valsalva is that there is no organic stenosis of ET. 
 ET function assessed by aspiration deflation method is considered to be a more 
physiological test. Choi et al 
52
 showed that in patients with mucosal chronic otitis media 
the ET was more likely to be blocked on modified inflation deflation test. He also showed 
that mucosal swelling and granulations were more frequently found in such patients.  
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MacKinnon
58
 in his study using this test found that with a negative middle ear pressure 
test, more patients with mucosal chronic otitis media showed a blocked ET. 
Virtanen
60
 in his study using this test, showed that most of the patients with 
mucosal chronic otitis media had a blocked ET with the inflation deflation method.  In the 
present study, too, we found that most patients had a blocked ET on the inflation- 
deflation test. The block was more evident when negative pressure was applied. In 
contrast, Andreasson and Harris
56
 in their study found most patients to have a patent ET 
on aspiration deflation test. This could be due to the short duration for doing the test, 
which do not pick up fluctuations in the ET function during a longer period and also other 
methods like yawning, moving the jaw or autoinflation which equilibrate the 
underpressure. 
Although our null hypothesis for this study was that there was no change in ET 
function with surgery, it was found on analysis of the results (when preoperative 
Valsalvamaneuver and inflation deflation were compared with postoperative 
tympanometry) that many of the non-patent ET became patent following surgery. This 
was quite different from those patients whose ET was patent preoperatively and this 
difference was statistically significant (p<0.001). This disproved our null hypothesis. 
However, when the results of preoperative and postoperative Valsalva were compared, 
the changes were not significant.  Similarly, Andreasson and Harris
56
 found that there was 
no change in a patient‟s ability to perform Valsalva maneuver and hence there was no 
change in ET function when assessed by Valsalva maneuver. However there was a 
significant change in ET function when assessed with the aspiration deflation test. Since 
none of their patients with a preoperative blocked ET had granulations or polyps blocking 
the ET, they suggested that the change in ET function was due to the change in the 
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environment in the closed middle ear cavity resulting in a change in the middle ear 
mucosal lining.  Also, a pressure difference occurs across the ET in a closed middle ear 
cavity which might act as a trigger for the ET to regain function. Our study clearly 
showed that ET function changed after surgical closure of the tympanic membrane 
perforation. The change was seen in a far greater number of patients than that showed by 
other studies. 
Tos
55 
in his study also showed that ET function changed for a number of patients 
after surgery. In a long term follow up, patients who persisted to have poor postoperative 
ET function had a higher chance of developing retractions and adhesions of the tympanic 
membrane. Choi et al
52
 in their study of patients with mucosal CSOM who underwent 
myringoplasty or tympanoplasty also showed that ET function changed after surgery. It 
was suggested that removal of mucosal edema and granulations blocking the ET probably 
resulted in the change in ET function. In contrast, the number of patients with change in 
ET function in Virtanen‟s60 study comparing preoperative aspiration deflation with 
postoperative tympanometry, were not many. His study does not support the hypothesis 
that ET function changes after surgery.  He suggested that this could not occur without 
intervention at the tubal orifice during surgery. He also suggested that the small pressure 
range used in tympanometric studies may be insufficient to move a tympanic membrane 
and hence may be inaccurate in assessing the normal aeration of middle ear. 
              The success rate of perforation closure in various studies in which ET function 
tests have been done varies from 74.5 %to 94.8% 
59‟ 52. In the present study the rate of 
tympanic membrane closure was 78.4%. The relatively high rate of residual perforation 
(21.6%) may be related to the fact that surgery was performed by surgeons with varying 
degree of skill, possible presence of infection introduced in the perioperative period, 
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resistant organisms and, of course, poor ET function. The importance of poor ET function 
as an etiological factor for residual perforation has been stressed by several authors.
50, 54, 
59
 Some authors have evaluated ET function in relation to successful closure of 
perforation in mucosal chronic suppurative otitis media also. Depending on the test used 
to assess ET function, variable results were obtained. 
The effect of ET function as assessed by the Valsalva maneuver on successful 
closure of tympanic membrane perforation was assessed in the present study. There 
appeared to be no correlation between preoperative Valsalva test result and the presence 
of either an intact tympanic membrane or residual perforation. Similar results were 
obtained by other authors.
56 
In the study by Reimer et al
59
, however, a patent ET on 
Valsalva was more likely to be associated with an intact tympanic membrane. His study 
also showed that ears with a combination of positive Valsalva and a functional volume of 
more than 2 ml had a better healing rate than those with a negative Valsalva and volume 
of less than 2 ml. There was no association between a blocked ET preoperatively and 
residual perforation. 
When the inflation deflation technique was used, some authors MacKinnon
58
 
found that healing was much more in patients with a good preoperative ET function than 
those who had bad ET function. A dry middle ear without any signs of infection and with 
a good or moderate preoperative ET function had more chance of healing after surgery. 
However on longer follow up in spite of a good ET function, the authors found that there 
was a chance of developing recurrent otitis media and tympanic membrane perforation in 
some individuals (10%). Choi et al
52
 showed that a good ET function was related to well 
aerated middle ear with an „A‟ type tympanogram and a good tympanic membrane 
compliance. Presence of middle ear granulations leads to defective gas exchange and can 
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also block the ET. Re-perforations in his study were seen in patients with diseased middle 
ear mucosa. Holmquist‟s54 study also showed a good correlation of preoperative ET 
function with results of myringoplasty. However Andreasson and Harris
56
 showed that 
there was no correlation between healing and preoperative ET function when assessed 
with the aspiration deflation method. According to the authors, the available ET function 
tests are of no value for selecting patients suitable for middle ear surgery. In the present 
study, we found an increased percentage of residual perforation in those with blocked ET 
when assessed by the inflation deflation test. However, this did not reach statistical 
significance (p=0.07) 
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CONCLUSION 
In conclusion, the results of our study on preoperative ET function in patients with 
mucosal CSOM show that the results of evaluation of ET function vary with the 
technique used. There appears to be no single test of ET function which may be 
consistently relied upon. However, the Valsalva tests and inflation deflation test are the 
easily performed and most popular. 
We arrived at 3 important conclusions in this study.  
Firstly, the ET appeared to be blocked in most (62.6%) patients with mucosal 
CSOM when assessed preoperatively with the inflation deflation test, whereas most 
appeared tube patent (54.9%) with the Valsalva maneuver. 
Secondly, there was a change in the ET function after surgery which was 
significant (p<0.001) when assessed with both Valsalva and inflation deflation 
preoperatively and tympanometry post operatively. The function of the ET tends to 
change from blocked towards patency, possibly due to the removal of the disease and 
return of normal physiological state after surgery.  
Finally, there was an increased tendency of a patient with blocked ET to develop a 
residual perforation, although this did not reach statistical significance.  
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APPENDIX A 
Proforma for study on Eustachian tube function before and after surgery for 
mucosal chronic suppurative ottitis media 
Name:                                                                      Age / Sex: 
Hospital number: 
Side:            Unilateral / Bilateral         Right            Left 
Address: 
Phone No: 
Symptoms: Right            Left 
Duration of ear discharge:            months              years 
Last episode of discharge: 
Associated ear symptoms: Tinnitus Vertigo Earache Hearing loss 
Nose and throat complaints: 
Other Co morbidities: 
Previous surgeries:         Right                   Left 
Signs: 
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Perforation size:  Pinpoint           Small          Large                     Subtotal 
Middle ear mucosa:                Dry,             Moist,                  Discharging,    Edematous        
Polypoidal       Granulations          
Pre OP Audiogram:  
 500Hz 
R          L 
1Khz 2Khz 3Khz PTA 
average 
Air bone 
gap 
average 
AC       
BC      
 
Pre OP X-ray mastoids:  Sclerosis    Cellular       
Pre OP Valsalva maneuver:   ET patent, ET blocked 
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Pre OP Inflation Deflation test: 
Residual pressure Present 
  R                               L 
               Absent 
   R                              L 
Inflation   
Deflation   
Surgery done: 
Date of surgery: 
Surgical findings:    
Middle ear Granulations Edematous mucosa          Tympanosclerosis 
                                Glue                      congested                        
Mastoid          Granulations          Edematous mucosa          Tympanosclerosis 
                                 Contracted             sclerotic                           cellular 
Aditus patency:    Patent        Block 
Ossicular erosion: Malleus:   Handle of Malleus;   Head of Malleus, Medialised 
                              Incus:  Lenticular process;   Long process; Body; Short process  
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                              Stapes:   Head; Crura 
Cartilage used:      Pallisades      Single piece 
Postop: 
Number of months postop:   
Otomicroscopy findings:  
Graft:  Intact             Residual perforation         Retracted           Tympanosclerosis 
Post OP Audiogram:  
 
 500Hz 
R          L 
1Khz 2Khz 3Khz PTA 
average 
Air-bone 
gap 
average 
AC       
BC      
 
Post OP Tympanometry: A As Ad B C 
Post OP Valsalva:    ET patent     ET blocked 
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APPENDIX B 
PATIENT INFORMATION SHEET 
You are being requested to participate in a study to assess your Eustachian tube (ET) 
function before and after your ear surgery. ET connects the ear to the nose and helps to 
equalize the pressure in the ear. Some studies have shown that ET function may have a 
bearing on the outcome of surgery (hearing, graft uptake etc.) Therefore we are 
conducting this study to see if this is true. 
 If you take part what will you have to do? 
You will be undergoing a surgery for the closure of your ear drum perforation with or 
without operation of the bone. If you agree to participate in this study we will be 
conducting the following test before surgery: 
1. Inflation-deflation test. This test will show the ET function in an ear with a 
perforation. 
2. Valsalva maneuver. This is another test of eustachian tube function. 
 
After surgery the following tests will be done at 3 months when you return for your 
regular postoperative check up  
1. Valsalva maneuver 
2. Tympanometry. This test will show the ET function in an ear without a 
perforation. 
The tests are non-invasive and not painful 
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Can you withdraw from this study after it starts? 
Your participation in this study is entirely voluntary and you are also free to 
decide to withdraw permission to participate in this study. If you do so, this will not affect 
your usual treatment at this hospital in any way.  
What will happen if you develop any study related injury? 
The tests done in this study are diagnostic and do not have any risk of injury.  
Will you have to pay for the tests?  
You will not have to pay for the additional tests 
Will your personal details be kept confidential? 
The results of this study will be published in a medical journal but you will not be 
identified by name in any publication or presentation of results. However, your medical 
notes may be reviewed by people associated with the study, without your additional 
permission, should you decide to participate in this study.  
If you have any further questions, please ask Dr. Lisa Mary Cherian, (tel: 
04162283483 mob: 09486233616) or email: lisamarycherian@gmail.com 
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INFORMED CONSENT TO TAKE PART IN A CLINICAL STUDY 
Study Title: Effect of ET function in postoperative graft uptake and hearing 
improvement 
Study Number: 
Participant’s name: 
Date of Birth / Age (in years): 
I_____________________________________________________________ 
___________, son/daughter of ___________________________________ 
(Please tick boxes) 
declare that I have read the information sheet provide to me regarding this study and have 
clarified any doubts that I had. [] 
I also understand that my participation in this study is entirely voluntary and that I am 
free to withdraw permission to continue to participate at any time without affecting my 
usual treatment or my legal rights [ ] 
I also understand that I will have to undergo some additional tests as part of the study for 
which I will not be charged. I also understand that I will receive free treatment for any 
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study related injury or adverse event but I will not receive any other financial 
compensation [ ] 
I understand that the study staff and institutional ethics committee members will not need 
my permission to look at my health records even if I withdraw from the trial. I agree to 
this access [ ]  
I understand that my identity will not be revealed in any information released to third 
parties or published [ ]  
I voluntarily agree to take part in this study [ ] 
Name: 
Signature: 
Date: 
 
Name of witness: 
Relation to participant: 
Date: 
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DATA SHEET OF STUDY PATIENTS (n=182) 
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1 PARAMESHWARI 43 2 1 1 3 15 2 1 2 2 2 2 
2 DEEPA M -1 32 2 2 1 5 30 2 1 2 2 2 2 
3 BHARATHIRAJA 1 * L 31 1 2 1 0.5 90 1 1 2 2 2 1 
4 JAYANTHA MONDAL 28 1 1 1 8 2190 1 1 2 2 1 1 
5 MANIVEL M 21 1 2 1 6 120 1 1 2 2 2 1 
6 SHAUKAT ALI -R 44 1 2 1 35 1 2 1 2 2 2 1 
7 BIDAN DAS 44 1 2 1 30 3 2 1 2 2 2 2 
8 VIJAYA KUMARI 30 2 2 1 20 30 2 1 1 2 2 2 
9 BISHNU CHARAN KARMAKAR 33 2 2 1 18 2555 2 1 2 2 2 1 
10 BAIKASHI GIRI 20 2 2 1 15 1 2 1 2 2 2 2 
11 RINA BASAK 27 2 1 1 7 4 1 1 2 2 2 1 
12 SATHYA SUMITHA 28 2 1 1 0.4 1 2 1 2 2 2 1 
13 DIPANKAR DAS 1 39 1 1 1 25 7 2 1 2 1 2 1 
14 JAYACHITRA -1 20 2 2 1 15 2 2 2 2 2 2 2 
15 KABITHA MONDAL 27 2 1 1 7 1 2 1 2 2 2 2 
16 MD.TAZOL ISLAM 29 1 1 1 20 30 1 1 2 2 2 2 
17 MANJUNATH 22 1 2 1 10 120 1 1 2 2 2 1 
18 KUMAR -R 22 1 2 1 25 60 2 1 2 2 1 1 
19 KUMAR -L 31 1 2 1 25 60 2 1 2 2 1 1 
20 SUKUMAR DEY PODDER 50 1 1 1 1 90 1 1 2 2 2 1 
21 MINATHI SARKAR 26 2 1 1 5 10 2 2 2 2 2 2 
22 KOLANJI 49 2 1 1 5 1 1 2 1 2 2 2 
23 AZIZA AKHTAR 26 2 2 1 24 1 1 1 2 2 2 2 
24 SHANTHI DEVI 55 2 1 1 2 5 2 2 1 2 1 1 
25 SAPAN DEY 33 1 1 1 23 2 1 2 2 2 1 2 
26 ABDUL RAHMAN 23 1 1 1 17 210 2 1 2 2 2 1 
27 MOUNI S 17 1 1 1 4 30 2 1 2 1 1 2 
28 JAHANGIR JAMADAR 34 1 2 1 30 20 1 1 2 2 2 2 
29 DIPAK GUPTA 46 1 1 1 0.75 30 1 2 2 2 2 1 
30 BHUVANESHWARI 36 2 1 1 32 10 2 1 1 2 2 2 
31 SATHYA 23 2 1 1 5 2 1 2 2 2 1 2 
32 SOUMEN GARANG 27 1 1 1 3 90 1 1 2 2 1 1 
33 NAZRUL ISLAM 18 1 2 1 10 60 2 1 2 2 2 2 
34 KALAVATHI 33 2 2 1 10 30 1 1 2 2 1 1 
35 RABIRAM TIMU 37 1 1 1 10 60 1 2 2 1 1 1 
36 PUSHPARANI-1 48 2 1 1 2 15 2 1 1 2 2 1 
37 TATAPUDI PRAKASH 29 1 1 2 N N 2 1 2 2 2 1 
38 KISHORE KUMAR GHOSH 19 1 2 1 6 730 1 1 2 2 1 1 
39 SHAYAM LAL AGARWAL 28 1 1 1 15 30 2 2 2 2 1 2 
40 RAJESHWARI * 31 2 1 1 1 210 1 2 2 2 2 1 
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1 23.75 1 2 2 2     1 1 2 3 1 13.75 1 2 
2 38.75 2 2 2 2 2 2 2 1 1 1 2 3 3  4 2 
3 18.75 2 1 1 2     1 1 2 14 1 26.25 1 1 
4 23.75 2 1 1 2     1 1 2 12 1 0 1 1 
5 25 1 2 2 1 2 2 2 1 1 1 2 7 1 25.25 3 2 
6 41.7 1 2 2 2 2 1 2 2 1 1 2 7 1 28.4 2 2 
7 11.7 1 2 2 2     1 1 2      
8 47.5 2 1 1 2 2 2 2 1 2 1 2 4 1 2.5 1 1 
9 35 2 1 2 2 2 1 1 1 1 1 2      
10 25 2 2 1 2 2 1 1 1 1 1 2      
11 20 2 2 1 1     1 1 2      
12 16.7 2 1 1 2 1 1 1 1 1 1 2 6 1 0 1 1 
13 23.75 2 2 2 2 2 1 1 1 2 2 2 12 1 21.25 3 2 
14 22.5 2 1 2 2 1 1 1 1 1 1 2 3 3  4 1 
15 31.6 2 1 1 2 2 2 2 2 1 1 2      
16 28.3 1 2 1 2     2 2 2      
17 0 2 2 2 2     3 3 2 3 1 0 1 2 
18 38.3 1 1 2 2     3 3 2      
19 45 1 2 2 2     3 3 2      
20 12.5 1 2 2 2     1 1 2 8 1 6.25 1 2 
21 18.3 2 2 2 2     1 1 2 6 1 0 1 1 
22 24.9 2 1 1 1 2 1 2 2 3 3 2 3 1 0 2 2 
23 50 2 2 2 2 2 2 2 1 2 2 1      
24 35 2 2 1 2     1 1 2 6 1 25 1 1 
25 21.6 2 2 2 2 2 1 1 1 1 1 2      
26 26.6 2 2 1 1     1 1 2 4.5 1 18.3 3 2 
27 26.6 2 1 2 1 2 1 1 1 1 1 2 4.5 1 0 1 1 
28 50 2 2 2 2 2 2 2 2 1 1 2 4.5 3  4 2 
29 15 2 1 1 2     1 1 2 6 1 0 1 1 
30 33.3 1 2 1 2 2 2 2 3 2 2 2      
31 25 1 2 1 1 1 1 2 1 1 1 2 3.5 1 11.7 2 1 
32 23.3 2 1 2 2 1 1 1 1 1 1 2 3 1 0 1 1 
33 52.5 2 2 2 2 2 2 2 3 1 1 2 12 3  4 2 
34 20 2 1 1 2     1 1 2 5 1 0 1 1 
35 20 2 1 1 2     1 1 2      
36 26.25 2 1 1 2 1 1 1 1 1 1 2 11 1 0 1 1 
37 28.3 2 2 2 1     1 1 2      
38 23.3 2 1 1 2     1 1 2 4 1 0 1 1 
39 26.7 2 1 2 2     1 1 2 3 1 0 1 1 
40 23.3 2 2 2 1     1 1 2 4 1 0 1 2 
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41 REBA BAR 42 2 1 1 1 120 1 1 2 2 2 1 
42 SYED BASHA 44 1 1 1 6 4 1 1 2 2 2 2 
43 KANCHAN ROY 44 1 2 1 1.5 547 2 1 2 2 2 1 
44 GOPAL RAO 26 1 1 1 10 730 2 2 2 1 1 1 
45 ARUP GOURAI * 22 1 1 1 10 30 2 1 2 2 1 1 
46 SANTHOSH GOPE 24 1 2 1 18 365 2 1 2 2 2 2 
47 BABITA CHULYA 38 2 1 1 25 365 2 1 1 1 1 1 
48 GITA RANI MONDAL 55 2 2 1 30 1 1 2 1 2 2 2 
49 SELVAM C  30 1 2 1 2 30 2 1 2 2 2 1 
50 SUMAN KUMARI 25 2 2 1 4 30 2 2 2 2 2 2 
51 SIVALINGAM 18 1 1 1 15 30 2 2 2 2 2 2 
52 SYFULLA 30 1 1 1 10 90 2 1 2 2 2 2 
53 TANUSHREE MONDAL 27 2 1 1 3 60 2 2 1 2 2 1 
54 TANUMOUY MAITY 20 1 1 1 3 60 2 1 2 2 1 2 
55 BERNAULI MAHATO *** 27 2 1 1 20 1 2 1 2 2 2 2 
56 V GOVINDASWAMY 57 1 1 1 5 90 2 2 2 2 1 1 
57 MALA MONDAL 42 2 2 1 26 120 1 1 2 2 1 1 
58 RUMKI NANDY 26 2 1 1 15 30 1 2 2 2 1 2 
59 ALTAB MONDAL 33 1 1 1 3 60 1 1 2 2 2 1 
60 PRANABESH PRADAN 36 1 1 1 28 120 2 2 2 2 1 1 
61 KALAVATHY * 38 2 1 2 N N 2 1 2 2 2 1 
62 MALLIGA .M 40 2 2 1 30 2 2 1 2 2 2 1 
63 LAKSHMI 36 2 2 1 2 4 2 1 2 2 2 2 
64 NILAVATI A 36 2 2 1 6 30 1 1 2 2 2 1 
65 SIMANT KUMAR 22 1 1 1 15 60 2 2 2 2 2 2 
66 ELUMALAI - I 36 1 2 1 20 21 1 1 2 2 2 2 
67 PHANI KALITA 46 1 2 1 30 90 2 1 1 1 2 2 
68 YUVARAJ - LEFT 23 1 2 1 20 30 1 2 2 2 2 1 
69 ASHIS KUMAR ADAK 35 1 1 1 20 1 2 2 1 2 2 2 
70 JEEVANANDAM 19 1 1 1 12 90 1 2 2 2 1 1 
71 VIGNESH * 19 1 2 1 10 45 2 2 2 2 2 2 
72 SHJEO ALAM 39 2 2 1 10 30 1 2 2 2 2 2 
73 KHUBLAL MONDAL - 2 40 1 2 1 6 60 1 2 2 2 2 1 
74 DHANALAKSHMI 19 2 1 1 7 30 2 1 2 2 1 1 
75 DEVIKA M 36 2 1 1 6 30 2 1 2 2 2 2 
76 BINA DEVI 54 2 1 1 30 4 2 2 2 2 2 2 
77 RAHIMA KHANAM MAZUMDER 43 2 1 1 2 1 2 1 2 2 2 2 
78 MARUFA BEGAM 34 2 2 1 20 1 1 2 2 2 2 2 
79 WAJIDA 32 2 1 1 5 60 2 2 2 2 2 2 
80 RAGHUNATH KUNDU 49 1 2 1 25 20 1 2 2 2 2 2 
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41 18.4 1 2 2 2     3 3 2      
42 30 2 2 2 2 2 2 2 3 1 1 2      
43 18.3 2 1 2 2     1 1 2 3 3  4 1 
44 40 2 1 1 2     1 1 2 3 1 45 1 1 
45 31.6 2 1 2 2     1 1 2 3 1 15 1 1 
46 31.6 2 1 2 2     1 1 2 5 1 15 1 1 
47 38.4 2 2 1 2     2 1 1 6 1 45 3 1 
48 21.6 2 2 2 2 2 1 1 1 1 1 2      
49 33.75 2 2 2 2 2 1 1 1 1 1 2      
50 20 1 2 2 2 1 1 2 1 1 1 2      
51 21.7 2 1 2 2 2 1 1 1 2 1 2 5 1 23.75 1 2 
52 60 2 2 2 2 2 1 1 1 2 2 1 3 1 23.4 1 1 
53 13.3 2 1 1 2 1 1 2 3 1 1 2 4 1 21.5 2 1 
54 15 2 2 1 1     2 2 2 3 1 0 1 2 
55 40 1 2 2 2 2 1 1 1 2 2 2 7 1 31.25 2 2 
56 23.4 1 1 2 2 2 1 1 1 2 1 2 7 1 8.75 1 1 
57 40 2 1 2 2 2 1 1 1 2 1 1 4 3  4 1 
58 41.6 1 1 1 2     1 1 2      
59 10 2 1 1 2     1 1 2      
60 15 2 1 1 2 2 1 1 1 1 1 2 4 1 0 1 1 
61 13.3 2 1 1 2     1 1 2 4 1 18.3 1 1 
62 18.6 2 1 2 2 1 1 1 1 1 1 2 3 1 0 1 2 
63 30 1 2 2 2 2 1 2 2 2 1 2 3 1 53.3 3 2 
64 20 1 2 2 2     1 1 2 5 1 2.5 1 2 
65 31.6 2 2 1 2 2 1 2 2 2 1 2 2 1 0 2 2 
66 27.25 2 2 2 1 2 2 2 1 1 1 2 6 1 13.75 1 2 
67 45 2 1 1 2 2 2 2 3 1 1 2 4 1 20 3 2 
68 33.3 2 1 1 2 2 2 2 3 1 1 2 3 1 0 1 1 
69 41.7 1 1 1 2 2 2 2 2 2 2 2 8 1 35 1 1 
70 20 2 2 2 2     3 3 2 3 1 0 1 1 
71 51.7 2 1 1 2 2 2 2 3 1 1 2 3 1 0 1 1 
72 37.5 2 2 2 2 2 2 2 1 1 1 2 4 1 16.25 2 2 
73 40 1 2 2 2     1 1 2      
74 33.3 2 1 2 2 2 2 1 1 1 1 2 4 1 18.75 1 1 
75 25 2 1 1 2 1 1 1 1 1 1 2 4 3  4 2 
76 40 1 1 2 2 2 2 2 3 3 3 2      
77 25 2 2 1 2 2 1 1 1 1 1 2 4 1 13.75 1 2 
78 38.4 1 1 1 1 2 2 2 2 2 2 2      
79 33.4 1 2 2 2 2 2 2 1 1 1 2 3 1 10 1 2 
80 50 2 1 1 2 2 2 2 1 1 1 2      
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81 AHMAD DIDAD 21 1 2 1 10 90 2 1 2 2 2 1 
82 BHAKTHI PADA GHOSH 49 1 2 1 35 60 2 1 2 1 2 1 
83 SURYA PRAKASH GOSH 40 1 1 1 2 30 2 1 2 2 2 2 
84 RINA DAS 20 2 2 1 10 730 1 1 2 2 2 2 
85 MOHAN V 23 1 1 1 16 365 2 2 2 2 1 2 
86 AMAR BARI RIGHT 22 1 2 1 15 30 1 1 2 2 2 2 
87 SARASWATHI MONDAL 24 2 2 1 7 90 1 2 2 2 2 1 
88 ARUN KUMAR 19 1 2 1 7 270 2 1 2 1 2 2 
89 BAKIYARAJ 22 1 1 1 15 60 1 2 2 2 1 1 
90 BHAGIRATH GAURAI 40 1 2 1 30 30 1 1 2 2 2 1 
91 VENKATESULU 40 1 2 1 20 2555 1 2 1 2 2 1 
92 ALEX PANDIAN 16 1 2 1 10 1 2 1 2 2 2 2 
93 DEVAN 19 1 2 1 12 30 1 1 2 2 2 1 
94 PRIYA 27 2 1 1 1 20 2 1 2 2 2 2 
95 BHAKTA DAS 30 2 2 1 20 120 2 1 2 2 2 2 
96 RENUKA BISWAS 38 2 1 1 2 21 1 1 2 2 2 1 
97 NANDHINI -R 19 2 2 1 15 7 2 1 2 2 2 2 
98 NANDHINI - L 19 2 2 1 15 7 2 1 2 2 2 2 
99 KALPANA GORAI 40 2 1 1 12 120 2 1 1 2 2 1 
100 JEEVITHA 24 2 2 1 15 4 2 1 2 2 2 2 
101 PRASANJIT MUKHERJEE 16 1 2 1 14 7 2 1 2 2 2 2 
102 NAVLESH KUMAR 19 1 1 1 12 90 1 1 2 2 2 2 
103 TAHIRA 50 2 1 1 2 4 1 1 1 2 1 1 
104 HARENDRA HAZARIKA 53 1 2 1 3 10 1 1 2 2 2 2 
105 POORNIMA UPADHYA 41 2 2 1 3 2 1 2 1 2 2 2 
106 ABHAY KUMAR SINGH 34 1 2 1 30 2 2 1 1 2 2 2 
107 SWAPAN DATTA 41 1 2 1 10 30 2 1 2 2 2 2 
108 FATHICK CHANDRA PRAMANIK L 41 1 2 1 35 60 2 1 2 2 2 2 
109 MUNIRATHINAM D 54 1 1 1 1 60 2 1 1 2 2 1 
110 NAJARAJ J 33 1 1 2 N N 2 1 2 2 1 1 
111 MUKHESH KUMAR 26 1 1 1 20 120 1 1 2 2 2 1 
112 SURESH -1 24 1 2 1 20 120 1 1 2 2 2 2 
113 KUMAR SADANAND 23 1 1 1 3 10 2 1 2 2 2 2 
114 SAHIDUL ISLAM 34 1 1 1 2 30 2 1 2 1 2 2 
115 NIRMALA 32 2 1 1 3 3 2 2 1 2 2 1 
116 KUNAL KANTHI 25 1 1 1 2 6 1 1 2 2 2 1 
117 FATHIMA 19 2 1 1 15 30 1 1 2 2 2 1 
118 SIMA RANI GHORAI 22 2 1 1 5 30 1 1 2 2 2 2 
119 SHAUKAT ALI -L 44 1 2 1 3 30 2 1 1 2 2 1 
120 RANG KYNSAIRYNJAI 33 1 1 1 6 2 2 1 2 2 2 2 
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81 32.5 1 2 2 2     1 1 2 3 1 20 3 2 
82 45 2 2 2 2 2 2 1 1 2 1 2 7 3  4 1 
83 48.75 2 1 2 2     1 1 2 3 3  4 1 
84 40 2 1 2 2 2 2 2 2 1 1 2      
85 33.3 2 1 2 2 2 2 2 1 1 1 2 3 3  4 1 
86 27.5 2 2 2 2 2 2 2 2 1 1 2 6 3  4 2 
87 40 2 1 2 2 2 1 1 1 1 1 2      
88 47.5 2 2 2 2     3 3 2 9 1 17.5 1 1 
89 15 2 1 2 1     1 1 2 3 1 0 1 2 
90 25 2 1 2 2 2 1 1 1 1 1 2      
91 25 2 2 2 2     1 1 2 9 3  4 2 
92 35 2 1 2 2 2 2 1 1 1 1 2 3 1 0 1 1 
93 41.6 2 1 1 2 2 2 1 1 1 1 2      
94 35 2 2 2 2 2 2 2 1 2 1 1      
95 43.4 2 1 2 2 2 2 2 1 1 1 2      
96 23.4 2 1 2 2 2 1 1 1 1 1 2 3 1 0 1 1 
97 46.7 2 2 2 2 2 2 2 3 2 2 2      
98 40 2 2 2 2     1 1 1      
99 20 2 2 2 2     1 1 2 3 3  4 2 
100 29.9 2 1 2 2 2 2 1 1 2 1 2      
101 35 2 1 2 2 2 2 1 1 2 2 2 5 1 32.5 3 2 
102 41.7 2 1 1 2 2 2 2 3 1 1 2 5 1 20 3 2 
103 38.3 2 2 2 2     1 1 2 4 3  4 2 
104 38.4 2 2 2 2 2 2 2 1 1 1 2      
105 56.6 2 1 2 2 2 2 2 1 1 1 2 5 1 22.5 1 1 
106 46.7 2 1 1 2 2 1 1 1 1 1 2      
107 38.4 2 1 2 2 2 2 1 1 1 1 2 4 1 36.25 2 2 
108 36.25 2 1 2 2 2 1 1 1 1 1 2 6 1 16.25 1 1 
109 30 1 2 2 2 2 1 1 1 1 1 2 4 3  4 2 
110 33.7 2 2 2 1 2 1 1 1 1 1 2 4 1 0 1 1 
111 45 2 1 2 2     2 1 2      
112 23.3 2 2 2 2 2 1 1 1 1 1 2 3 1 0 1 1 
113 26.6 2 2 2 2 1 1 1 1 1 1 2      
114 33.4 1 1 2 2 2 2 2 1 2 2 1 4 1 31.25 1 1 
115 26.7 2 2 2 2 1 1 1 1 1 1 2      
116 45 1 1 1 2     1 1 2 5 3  4 1 
117 43.75 1 2 2 2 2 1 2 2 1 1 2 4 1 16.25 1 1 
118 37.5 1 1 1 2 2 2 2 1 1 1 2 3 1 0 1 1 
119 31.7 1 2 2 2 2 2 2 2 1 1 2 3 3  4 2 
120 23.3 2 1 1 2 2 1 1 1 1 1 2      
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121 VANMATHI -1 17 2 2 1 15 2 2 2 2 2 2 2 
122 TAPOSH KUMAR DAS 43 1 1 1 8 4 2 1 2 1 2 1 
123 ARAVIND KUMAR 20 1 2 1 10 1 1 1 2 2 2 2 
124 SATHYA DEVI -1 27 2 1 1 2 7 2 2 2 2 2 2 
125 PUSPALATHA  27 2 1 1 1 45 1 1 2 2 2 1 
126 SURESH. S -1 21 1 1 1 0.5 180 2 1 2 2 2 1 
127 SATHYA. C  23 2 1 1 2 1 1 1 2 2 2 2 
128 HIMANSHU 35 1 2 1 20 3 1 1 2 2 2 2 
129 RAGHUPATHY 35 1 2 2 N N 2 1 2 2 2 1 
130 GUNA .S 42 2 1 1 3 60 2 1 2 2 1 1 
131 SHARMILA 24 2 2 1 15 90 2 1 2 2 2 2 
132 BINOY KUMAR 37 1 2 1 12 15 2 1 2 2 2 2 
133 SANTHOSH GOPE 24 1 2 1 18 365 2 1 2 2 2 2 
134 VENKATESAN 59 1 1 1 7 90 2 1 2 2 2 1 
135 AKRAMUL HAQUE SHEIK - 1 49 1 1 1 6 365 1 1 2 2 2 2 
136 PARITHOSH GHOSH 43 1 2 1 10 90 2 1 2 2 2 1 
137 KARPAGAM 54 2 1 1 7 7 1 1 2 2 1 2 
138 MADAN KUMAR 1 18 1 2 1 16 45 2 1 2 2 2 1 
139 MADAN KUMAR 1 18 1 2 1 16 45 2 1 2 2 2 1 
140 GOPI .R 27 1 2 1 20 5475 2 1 2 2 2 1 
141 YUVARAJ - RIGHT 23 1 2 1 20 30 1 2 2 2 2 1 
142 LAKSHMI R 50 2 2 1 1 7 2 1 2 2 1 2 
143 DEEPAK KUMAR 23 1 1 1 1.5 45 2 1 2 2 2 1 
144 DILIP KUMAR SARKAR 50 1 2 1 1.5 90 2 1 2 2 2 1 
145 NAMITA MONDAL 56 2 1 1 50 3 2 1 2 2 2 1 
146 KALPANA S 32 2 1 1 30 7 2 1 2 2 2 2 
147 SASIKALA S 27 2 1 1 1 365 2 1 2 1 2 2 
148 MURUGAN B 34 1 1 1 10 30 2 1 2 2 2 1 
149 BINA SINGH 37 2 1 1 15 1 1 1 2 2 2 2 
150 CHIRANJIVI SHARMA 42 1 1 1 34 120 1 1 1 2 2 1 
151 
SNEHANSHU 
CHAKRABRTHY 40 1 1 1 14 270 1 1 2 1 2 2 
152 SANTHOSH R 26 1 1 1 5 180 2 1 2 2 2 2 
153 SABITA ROY 58 2 2 1 5 30 1 1 2 2 1 2 
154 IBRAHIM ALI 39 1 1 1 15 30 1 1 2 2 2 1 
155 PANKAJ KUMAR SAW 29 1 2 1 20 90 2 1 2 2 2 2 
156 LALITHA SHARMA 57 2 1 1 1 30 2 1 2 2 2 1 
157 MUTHULAKSHMI 45 2 1 1 0.58 1 1 1 2 2 1 2 
158 SUSHIL SAMANTA 45 1 1 1 15 150 1 1 2 2 2 1 
159 RAJARAJAN - 1  42 1 1 1 3 60 1 1 1 1 2 1 
160 SWATHI - 1 17 2 1 1 2 150 2 1 2 2 1 1 
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121 23.3 2 2 2 2 2 1 1 1 1 1 2      
122 38.4 1 2 2 2 2 1 1 1 1 1 2 3 3  4 2 
123 35 2 1 1 2 2 2 2 1 1 1 2      
124 23.3 2 1 2 1 1 1 1 1 2 2 1      
125 32.5 2 2 1 2 2 1 1 1 1 1 2 3 1 0 1 2 
126 15 2 1 1 2     1 1 2 3 1 0 1 1 
127 40 2 1 2 1 2 2 2 1 2 1 2      
128 33.75 2 1 2 2 2 1 1 1 1 1 2      
129 10 2 1 1 2     1 1 2 3 1 0 2 1 
130 39.75 1 1 1 2     1 1 2 3 1 41.4 1 1 
131 12.5 2 1 1 2     1 1 2      
132 23.75 1 2 1 2 2 2 2 1 1 1 2      
133 40 2 1 2 2 2 2 2 2 1 1 2 3 1 0 1 1 
134 16.25 1 1 1 2 2 2 2 1 1 1 2 4 3  4 1 
135 26.25 2 1 1 2     1 1 2      
136 40 2 1 1 1     2 2 2 4 1 36.25 1 1 
137 30 2 1 2 2 2 2 1 1 1 1 1 3 1 36.25 3 2 
138 45 2 1 2 2 2 1 1 1 2 2 2 9 1 0 1 1 
139 23.75 2 1 2 2 2 1 1 1 2 2 2 5 3  4 1 
140 23.75 2 1 2 2 2 2 2 1 1 1 2 3 1 18.75 1 1 
141 30 2 1 1 2 2 2 2 1 1 1 2 3 1 0 1 1 
142 43.75 2 2 2 2 2 1 1 1 1 1 2      
143 15 2 2 1 2     1 1 2      
144 50 1 2 2 2 1 1 1 1 1 1 2      
145 35 1 1 2 2     1 1 2 3 3  4 1 
146 42.5 2 1 1 2 2 2 2 2 2 2 2 3 3  4 2 
147 17.5 2 2 1 2     1 1 2      
148 23.75 2 2 2 2 2 1 2 2 1 1 2 3 1 20 1 1 
149 38.5 1 1 1 2 2 2 2 2 1 1 2      
150 21.25 2 2 2 2 1 1 1 1 1 1 2      
151 37.5 2 1 1 2 1 1 2 2 1 1 2      
152 17.5 2 1 2 2     1 1 2 3 1 13.75 3 1 
153 18.75 2 2 1 1     1 1 2      
154 35 1 1 2 1 2 1 1 1 1 1 2      
155 31.25 2 2 2 2 2 2 1 1 1 1 2      
156 16.25 1 2 2 2     1 1 2 3 1 0 1 1 
157 26.25 2 2 2 2 2 2 2 2 1 1 2 15 1 12.75 1 2 
158 28.75 1 1 2 2 2 1 1 1 1 1 2      
159 28.75 1 1 1 2 2 2 2 2 1 1 2      
160 30 2 2 2 1     1 1 2      
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161 AMAR BARI LEFT 22 1 2 1 15 30 1 1 2 2 2 2 
162 SAJJADALI MONDAL 41 1 1 1 7 150 1 1 2 1 2 1 
163 VIVEKANANDAN 31 1 1 1 2 30 1 1 2 2 2 1 
164 RAMANI -1 45 2 1 1 2 90 2 1 2 2 2 1 
165 SELVAM R  41 1 1 1 4 60 2 1 2 2 1 1 
166 ANJUMANARA AKTER BEAUTY 24 2 1 1 5 20 1 1 2 2 2 1 
167 BISWAJIT BANIK 25 1 1 1 4 60 1 1 2 2 2 1 
168 THAMILARASI 26 2 1 1 0.08 30 2 1 2 2 2 1 
169 DHIVYA R 21 2 1 1 15 30 1 1 2 2 2 2 
170 NAVEEN TAJ 17 2 2 1 10 1825 2 1 2 2 2 2 
171 GOPAL CHAKRABORTHY 48 1 1 1 0.416 30 1 1 1 2 2 2 
172 UTHIRAPATHY 21 1 1 1 10 30 2 1 2 2 2 1 
173 MUSLIMA KHATUN 46 2 1 1 2 30 2 1 2 2 1 2 
174 MITUNJOY GANGALY 28 1 1 1 15 14 2 1 2 2 2 2 
175 SIVALINGAM L 19 1 2 1 5 60 2 2 2 2 1 1 
176 RESHMA PERVEEN 28 2 1 1 5 180 2 1 2 2 2 1 
177 MANORMANI  41 2 1 1 30 30 2 1 2 2 2 1 
178 RANI 49 2 2 1 2 365 2 1 2 2 2 1 
179 BHARATHIRAJA 1 R 32 1 2 1 1.5 45 1 1 2 2 1 1 
180 NIRMALA K 20 2 2 1 10 30 2 1 2 2 2 2 
181 SAKTHIVEL. C 17 1 2 1 10 7 2 1 2 2 2 1 
182 FATHICK CHANDRA PRAMANIK L 41 1 2 1 35 60 2 1 2 2 2 2 
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161 33.75 2 2 2 2 2 2 2 1 1 1 2 3 1 20 2 2 
162 30 2 1 1 1 2 1 1 1 1 1 2      
163 22.5 2 1 2 2     1 1 2      
164 20 2 2 1 2     1 1 2      
165 26.25 1 2 2 2     1 1 2      
166 48.75 2 2 2 2 2 2 2 2 1 2 2      
167 21.25 2 1 2 1     1 1 2      
168 42.5 2 1 1 2     1 1 2      
169 53.75 1 2 2 2 2 2 1 1 1 1 2      
170 47.5 2 2 2 1     1 1 2 3 1 43.75 3 2 
171 28.75 1 2 2 2     1 1 2      
172 45 2 1 2 1     1 1 2      
173 22.25 1 2 1 2 1 2 2 1 2 2 1 3 1 31.25 2 2 
174 42.5 2 1 2 2 2 2 2 1 1 1 2      
175 0 2 1 2 2 2 1 1 1 1 1 1      
176 47.5 2 1 1 2     1 1 2      
177 52.5 2 1 1 2     1 1 2 3 1 28.75 1 2 
178 26.25 2 1 1 1     1 1 2 3 3  4 1 
179 30 2 1 2 1     1 1 2      
180 36.25 2 1 1 2 2 1 1 1 1 1 2 2 1 22.5 1 1 
181 26.75 2 1 2 2 2 2 2 2 1 1 2      
182 25 2 1 2 2 2 1 1 1 1 1 2      
 
